Delpharm

About Delpharm

Delpharm is a worldwide leader in contract development and manufacturing of medicines for pharmaceutical companies. The company manufactures annually more than one billion units in its manufacturing and development sites providing the majority of available dosage forms on the market: tablets, injectable vials / ampoules / prefilled syringes, freeze dry, suspensions, solutions, ointments and soft gels.The company employs more than 6,500 people and has achieved in 2022 a revenue of €1 billion.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • FR
  • 2015
    On CPHI since
  • 4
    Certificates
  • 5000+
    Employees
Company types
Contract Service
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024
View Exhibitor Profile

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

Products from Delpharm (5)

  • Prefilled Syringes

    Product Prefilled Syringes

    Delpharm group offers pharmaceutical services which includes glass prefilled syringes.  Capsules. Contact us for more information.
  • Biotech

    Product Biotech

    - Cell culture
    - Diagnostics
  • Capsules

    Product Capsules

    Delpharm group offers pharmaceutical services which includes capsules. It belongs to solid forms category. Capsules. Contact us for more information.
  • Coated tablets

    Product Coated tablets

    Delpharm group offers pharmaceutical services which includes coated tablets. It belongs to solid forms category. Semisolids: creamscoated tabletsdrops. Specialties: cytotoxic. Contact us for more information.
  • Film-coated tablets

    Product Film-coated tablets

    Delpharm group offers pharmaceutical services which includes film-coated tablets. It belongs to solid forms category. Semisolids: suppositories film-coated tablets bulbs. Specialties: sterile injectable. Contact us for more information.

Delpharm Resources (2)

  • GSK agrees to sell its Poznań manufacturing site to Delpharm.

    News GSK agrees to sell its Poznań manufacturing site to Delpharm.

    Poznań, Poland, Thursday 15 October 2020 –GSK and Delpharm announced today they have entered into an agreement under which Delpharm will acquire GSK’s Poznań manufacturing facility in Poland.
    21 Jun 2021
  • Delpharm Overview

    Brochure Delpharm Overview

    Delpharm is a Worldwide leader in contract manufacturing and development of medicines for pharmaceutical laboratories. It owns 17 manufacturing plants (12 in France, 2 in Italy, 1 in Belgium, 1 in the Netherlands and 1 in Canada) providing the majority of dosage forms available on the market: tablets, syrups, bottles, vials, etc. Delpharm generates €800m in turnover and is wholly-owned by its management. For more information, visit our website: http://www.delpharm.com/